Covid-19: Nursing homes to face action by BMC
In a statement issued by BMC that it will issue notices to around 25% of the total 1,496 nursing homes in the city asking them why the nursing homes should…
High time to innovate in Pharma sector to do business differently
“Its a high time that has come for pharma firms to innovate and do business differently”, says Dr Dinesh Dua, CEO and Whole-time Director, Nectar Lifesciences Ltd and chairman, Pharmexcil,…
Covid-19: Pharma companies to play important role in India
The Indian pharmaceutical companies are well-known for producing affordable low-cost medicines and in upcoming time these companies will play an important role in the global fight against the novel coronavirus…
Uber-MedLife tie-up violates Drug & Cosmetics Act: AIOCD seeks ban on delivery of drugs through online
The All India Organisation of Chemists and Druggists (AIOCD), a representative body of 8.5 lakh chemists across the country with recent collaboration between ride-hailing platform Uber and e-pharmacy player MedLife…
Covid-19: Indian & US pharma majors collaborated to develop vaccine
New Delhi: The Serum Institute of India has joined hands together with New York-based Codagenix Inc for developing of a vaccine against the deadliest coronavirus. According to a press statement,…
Caplin gets approval for generic Naropin injection by USFDA
Caplin Steriles Limited, a formatiom of Caplin Point Laboratories Limited granted final approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) ropivacaine…
EIR recieved by Lupin from USFDA
India: Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) after closure of the U.S. FDA inspection of its Nagpur, India facility. The inspection was carried out…
Medical Device Import Lobby Surreptitiously stings ‘Make In India’ via COVID
New Delhi: Indigenous medical device industry has been left to lick its wounds by the decision of government of India to reduce duty on import of Masks, Ventilators and PPE…
Malaria drug is biggest hope against coronavirus: Novartis CEO
Swiss newspaper SonntagsZeitung reported that Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit’s malaria, lupus and arthritis drug hydroxychloroquine is the company’s biggest hope against the coronavirus. Novartis…
Only 10 lakh hydroxy-chloroquine tablets to be supplied by Bengal Chemical
Recommendations has been made by the Indian Council of Medical Research (ICMR) for use of hydroxy-chloroquine for healthcare workers involved in the care of suspected or confirmed Covid-19 cases and…
